Showing 921 - 940 results of 17,985 for search 'significant ((((teer decrease) OR (we decrease))) OR (a decrease))', query time: 0.53s Refine Results
  1. 921
  2. 922
  3. 923
  4. 924
  5. 925
  6. 926

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Herein, we reported a facile and green process for fabricating biodegradable and flexible gold ion (Au<sup>3+</sup>)-coordinated cellulose-based light filters with diverse UV- and HEBL-screening capacities via adsorption of Au<sup>3+</sup>. …”
  7. 927

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Herein, we reported a facile and green process for fabricating biodegradable and flexible gold ion (Au<sup>3+</sup>)-coordinated cellulose-based light filters with diverse UV- and HEBL-screening capacities via adsorption of Au<sup>3+</sup>. …”
  8. 928

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Herein, we reported a facile and green process for fabricating biodegradable and flexible gold ion (Au<sup>3+</sup>)-coordinated cellulose-based light filters with diverse UV- and HEBL-screening capacities via adsorption of Au<sup>3+</sup>. …”
  9. 929

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Herein, we reported a facile and green process for fabricating biodegradable and flexible gold ion (Au<sup>3+</sup>)-coordinated cellulose-based light filters with diverse UV- and HEBL-screening capacities via adsorption of Au<sup>3+</sup>. …”
  10. 930
  11. 931
  12. 932

    Anthelmintics Derived from the Kinase Inhibitor SGI-1776 for the Treatment of Gastrointestinal Worm Infections by Mostafa A. Elfawal (22430138)

    Published 2025
    “…The unexpected SAR of compound <b>15</b> can be explained by computational modeling. We demonstrate the efficacy of optimized compound <b>50</b> as a new oral anthelmintic, which demonstrated better gut restriction properties and significantly reduced the fecundity of T. muris whipworm adults in infected mice. …”
  13. 933
  14. 934
  15. 935
  16. 936
  17. 937

    Clinical characteristics of the study population. by Hun Gi Lee (21526538)

    Published 2025
    “…The total number of patients who met with P-TAs was 26,842, with a 43.1% reduction from 17,105–9,737. A decrease was observed across all age groups; however, the rate was lower in the geriatric and severely injured groups. …”
  18. 938

    List of Included studies. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  19. 939

    The search strategy in three databases. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  20. 940

    NIH score. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”